Showing results (321-330 of 365) with videos related to
Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.HIV Medicine|February 18, 2015
Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care systemE J Edelman, J P Tate, D A Fiellin, et al.Drug and Alcohol Dependence|December 11, 2020
Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatmentEdouard Coupet, Gail D'Onofrio, Marek Chawarski, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2021
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical PracticeMartin J Edelman, Daniel P Raymond, Dwight H Owen, et al.Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected PatientsDaniel F Weisberg, Kirsha S Gordon, Declan T Barry, et al.JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2018
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)Ajeet Gajra, Tyler J Zemla, Aminah Jatoi, et al.Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancerMartin J Edelman, Ming T Tan, Mary J Fidler, et al.Pageof 37